New England Journal of Medicine




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

Private Equity and Physician Medical Practices — Navigating a Changing Ecosystem

Jane M. Zhu, M.D., M.P.P., M.S.H.P., and Daniel Polsky, Ph.D., M.P.P.

doi : 10.1056/NEJMp2032115

N Engl J Med 2021; 384:981-983

Buy The Package and View The Article Online


The Good Doctor — Jack Geiger, Social Justice, and U.S. Health Policy

Sara Rosenbaum, J.D., and Daniel R. Hawkins, Jr., B.A.

doi : 10.1056/NEJMp2036296

N Engl J Med 2021; 384:983-985

Buy The Package and View The Article Online


My Intern

Richard E. Leiter, M.D.

doi : 10.1056/NEJMp2004154

N Engl J Med 2021; 384:986-987

Buy The Package and View The Article Online


Once-Weekly Semaglutide in Adults with Overweight or Obesity

John P.H. Wilding, D.M., Rachel L. Batterham, M.B., B.S., Ph.D., Salvatore Calanna, Ph.D., Melanie Davies, M.D., Luc F. Van Gaal, M.D., Ph.D., Ildiko Lingvay, M.D., M.P.H., M.S.C.S., Barbara M. McGowan, M.D., Ph.D., Julio Rosenstock, M.D., Marie T.D. Tran, M.D., Ph.D., Thomas A. Wadden, Ph.D., Sean Wharton, M.D., Pharm.D., Koutaro Yokote, M.D., Ph.D., Niels Zeuthen, M.Sc., and Robert F. Kushner, M.D. for the STEP 1 Study Group*

doi : 10.1056/NEJMoa2032183

N Engl J Med 2021; 384:989-1002

Obesity is a global health challenge with few pharmacologic options. Whether adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 mg as an adjunct to lifestyle intervention has not been confirmed.

Buy The Package and View The Article Online


Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

Lawrence Corey, M.D., Peter B. Gilbert, Ph.D., Michal Juraska, Ph.D., David C. Montefiori, Ph.D., Lynn Morris, Ph.D., Shelly T. Karuna, M.D., Srilatha Edupuganti, M.D., Nyaradzo M. Mgodi, M.B., Ch.B., M.Med., Allan C. deCamp, Ph.D., Erika Rudnicki, M.S., Yunda Huang, Ph.D., Pedro Gonzales, M.D., Robinson Cabello, M.D., Catherine Orrell, M.B., Ch.B., Ph.D., Javier R. Lama, M.D., M.P.H., Fatima Laher, M.B., B.Ch., Erica M. Lazarus, M.B., Ch.B., Jorge Sanchez, M.D., M.P.H., Ian Frank, M.D., Juan Hinojosa, M.D., Magdalena E. Sobieszczyk, M.D., M.P.H., Kyle E. Marshall, M.S., Pamela G. Mukwekwerere, M.B., Ch.B., Joseph Makhema, M.B., Ch.B., Lindsey R. Baden, M.D., James I. Mullins, Ph.D., Carolyn Williamson, Ph.D., John Hural, Ph.D., M. Juliana McElrath, M.D., Ph.D., Carter Bentley, Ph.D., Simbarashe Takuva, M.B., Ch.B., Margarita M. Gomez Lorenzo, M.D., David N. Burns, M.D., Nicole Espy, Ph.D., April K. Randhawa, Ph.D., Nidhi Kochar, M.S., Estelle Piwowar-Manning, M.T., Deborah J. Donnell, Ph.D., Nirupama Sista, Ph.D., Philip Andrew, R.N., James G. Kublin, M.D., Glenda Gray, M.B., B.Ch., Julie E. Ledgerwood, D.O., John R. Mascola, M.D., and Myron S. Cohen, M.D. for the HVTN 704/HPTN 085 and HVTN 703/HPTN 081 Study Teams*

doi : 10.1056/NEJMoa2031738

N Engl J Med 2021; 384:1003-1014

Whether a broadly neutralizing antibody (bnAb) can be used to prevent human immunodeficiency virus type 1 (HIV-1) acquisition is unclear.

Buy The Package and View The Article Online


Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

Michael J. Joyner, M.D., Rickey E. Carter, Ph.D., Jonathon W. Senefeld, Ph.D., Stephen A. Klassen, Ph.D., John R. Mills, Ph.D., Patrick W. Johnson, B.S., Elitza S. Theel, Ph.D., Chad C. Wiggins, Ph.D., Katelyn A. Bruno, Ph.D., Allan M. Klompas, M.B., B.Ch., B.A.O., Elizabeth R. Lesser, M.S., Katie L. Kunze, Ph.D., Matthew A. Sexton, M.D., Juan C. Diaz Soto, M.D., Sarah E. Baker, Ph.D., John R.A. Shepherd, M.D., Noud van Helmond, M.D., Nicole C. Verdun, M.D., Peter Marks, M.D., Ph.D., Camille M. van Buskirk, M.D., Jeffrey L. Winters, M.D., James R. Stubbs, M.D., Robert F. Rea, M.D., David O. Hodge, M.S., Vitaly Herasevich, M.D., Ph.D., Emily R. Whelan, B.S., Andrew J. Clayburn, B.S., Kathryn F. Larson, M.D., Juan G. Ripoll, M.D., Kylie J. Andersen, B.S., Matthew R. Buras, M.S., Matthew N.P. Vogt, M.D., Joshua J. Dennis, B.S., Riley J. Regimbal, B.S., Philippe R. Bauer, M.D., Ph.D., Janis E. Blair, M.D., Nigel S. Paneth, M.D., M.P.H., DeLisa Fairweather, Ph.D., R. Scott Wright, M.D., and Arturo Casadevall, M.D., Ph.D.

doi : 10.1056/NEJMoa2031893

N Engl J Med 2021; 384:1015-1027

Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19) under the presumption that such plasma contains potentially therapeutic antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can be passively transferred to the plasma recipient. Whether convalescent plasma with high antibody levels rather than low antibody levels is associated with a lower risk of death is unknown.

Buy The Package and View The Article Online


Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, M.B., Ch.B., Ph.D., Jeff Szer, M.B., B.S., Ilene Weitz, M.D., Alexander R?th, M.D., Britta H?chsmann, M.D., Jens Panse, M.D., Kensuke Usuki, M.D., Ph.D., Morag Griffin, B.M.Sc., M.B., Ch.B., Jean-Jacques Kiladjian, M.D., Ph.D., Carlos de Castro, M.D., Hisakazu Nishimori, M.D., Ph.D., Lisa Tan, R.N., Mohamed Hamdani, M.S., Pascal Deschatelets, Ph.D., Cedric Francois, M.D., Ph.D., Federico Grossi, M.D., Ph.D., Temitayo Ajayi, M.D., Antonio Risitano, M.D., Ph.D., and Régis Peffault de la Tour, M.D., Ph.D.

doi : 10.1056/NEJMoa2029073

N Engl J Med 2021; 384:1028-1037

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired disease characterized by chronic complement-mediated hemolysis. C5 inhibition controls intravascular hemolysis in untreated PNH but cannot address extravascular hemolysis. Pegcetacoplan, a pegylated peptide targeting proximal complement protein C3, potentially inhibits both intravascular and extravascular hemolysis.

Buy The Package and View The Article Online


Extrahepatic Manifestations of Chronic HCV Infection

Patrice Cacoub, M.D., and David Saadoun, M.D., Ph.D.

doi : 10.1056/NEJMra2033539

N Engl J Med 2021; 384:1038-1052

Buy The Package and View The Article Online


Sulfonamide Crystals

Kanin Thammavaranucupt, M.D., and Ittikorn Spanuchart, M.D.

doi : 10.1056/NEJMicm2028020

N Engl J Med 2021; 384:1053

Buy The Package and View The Article Online


Painful Nodules on the Arms

Qianya Su, M.D., and Fei Wang, M.D., Ph.D.

doi : 10.1056/NEJMicm2028530

N Engl J Med 2021; 384:e41

Buy The Package and View The Article Online


Case 8-2021: A 34-Year-Old Woman with Cholangiocarcinoma

Lipika Goyal, M.D., Christopher T. Chen, M.D., Theodore T. Pierce, M.D., and Vikram Deshpande, M.D.

doi : 10.1056/NEJMcpc2027092

N Engl J Med 2021; 384:1054-1064

Buy The Package and View The Article Online


STEP 1 for Effective Weight Control — Another First Step?

Julie R. Ingelfinger, M.D., and Clifford J. Rosen, M.D.

doi : 10.1056/NEJMe2101705

N Engl J Med 2021; 384:1066-1067

Buy The Package and View The Article Online


The AMP Trials — A Glass Half Full

Bruce D. Walker, M.D.

doi : 10.1056/NEJMe2101131

N Engl J Med 2021; 384:1068-1069

Buy The Package and View The Article Online


Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses

Eric J. Rubin, M.D., Ph.D., Lindsey R. Baden, M.D., and Stephen Morrissey, Ph.D.

doi : 10.1056/NEJMe2104584

N Engl J Med 2021; 384:e53

Buy The Package and View The Article Online


The Political Nature of Sex — Transgender in the History of Medicine

Ketil Slagstad, M.D.

doi : 10.1056/NEJMms2029814

N Engl J Med 2021; 384:1070-1074

Buy The Package and View The Article Online


Face Transplantation in a Black Patient — Racial Considerations and Early Outcomes

doi : 10.1056/NEJMc2033961

N Engl J Med 2021; 384:1075-1076

Buy The Package and View The Article Online


Spontaneous Coronary-Artery Dissection

doi : 10.1056/NEJMc2100339

N Engl J Med 2021; 384:1077-1078

Buy The Package and View The Article Online


Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes

doi : 10.1056/NEJMc2036175

N Engl J Med 2021; 384:e42

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?